arrow_back Back to App

US participation in epidemic fight: supporting vaccine development

This act authorizes the United States to join the international organization CEPI, which supports the development of vaccines against new diseases. This will allow the US to contribute to faster vaccine creation and global distribution, enhancing citizens' health security and helping prevent future pandemics.
Key points
The US joins the global CEPI initiative, which funds research into vaccines for new epidemic threats.
The goal is faster development and access to vaccines, protecting citizens from diseases and their economic impacts.
The US President will appoint a representative to the organization's council, ensuring influence over its activities.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2118
Sponsor: Rep. Bera, Ami [D-CA-7]
Process start date: 2021-03-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Securing America From Epidemics Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2118.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-23.

What are the main provisions?

Key points include:

  • The US joins the global CEPI initiative, which funds research into vaccines for new epidemic threats.
  • The goal is faster development and access to vaccines, protecting citizens from diseases and their economic impacts.
  • The US President will appoint a representative to the organization's council, ensuring influence over its activities.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Bera, Ami [D-CA-7].

What is the latest detailed status?

The latest detailed status is: Pursuant to section 7 of H. Res. 535, and the motion offered by Mr. Hoyer, the following bills passed under suspension of the rules: H.R. 678; H.R. 1036; H.R. 1079, as amended; H.R. 1158; H.R. 1250; H.R. 1754; H.R. 1833, as amended; H.R. 1850; H.R. 1871; H.R. 1877, as amended; H.R. 1893; H.R. 1895; H.R. 2118; H.R. 2795, as amended; H.R. 2928; H.R. 2980, as amended; H.R. 3003; H.R. 3138, as amended; H.R. 3223; H.R. 3263; and H.R. 3264; and the following resolutions were agreed to under suspension of the rules: H. Res. 277; and H. Res. 294. (consideration: CR H3715-3730; text: CR H3721)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Public Investments